Sleep drug could curb alcohol cravings, early study suggests
NCT ID NCT06326684
Summary
This early-stage study is testing whether suvorexant, a medication currently used for insomnia, can reduce the urge to drink alcohol in people with alcohol use disorder. Researchers will observe 30 participants in a controlled inpatient setting to see if the drug decreases their motivation to choose alcohol over money and reduces other alcohol-related behaviors. The goal is to gather initial evidence about whether targeting the brain's orexin system could help control problematic drinking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Psychopharmacology of Addiction Laboratory
RECRUITINGLexington, Kentucky, 40507, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.